We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

November 22, 2010

JAZZ PHARMACEUTICALS, INC. v. ROXANE LABORATORIES, INC.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. June 19, 2015

    Roxane Can Fix Arguments In Jazz's Xyrem Patent Suit

    A New Jersey federal judge denied Jazz Pharmaceuticals Inc.'s appeal of an order allowing Roxane Laboratories Inc. to amend its invalidity and noninfringement arguments in a suit over a planned generic of Jazz's narcolepsy drug Xyrem, saying Friday the amendments are timely.

1 other articles on this case. View all »

Parties

To view the parties, register now.